Dosimetric Comparison of Doses in Both Positions (Prone and Decubitus) for Patient With Breast Cancer
NCT ID: NCT02704312
Last Updated: 2022-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
11 participants
INTERVENTIONAL
2015-11-30
2022-02-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning Study
NCT01284153
Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy
NCT00887692
Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy
NCT06902051
Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions
NCT03280719
Validation of Prone Crawl Radiotherapy for Whole-breast Irradiation After Breast Conserving Surgery
NCT05179161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Radiotherapy techniques
Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk. The technique used is that of which the dose on the organs at risk is as low as possible, and whose dose to the target volume is the closest possible to the prescribed dose (100% of the prescribed dose)
Radiotherapy by Prone and decubitus
Dosimetric comparison of doses in target volumes and organs at risk
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiotherapy by Prone and decubitus
Dosimetric comparison of doses in target volumes and organs at risk
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged over 18 years
* Patients with indication for conservative surgery.
* Resection should be in healthy margin.
* Women of childbearing potential must satisfy a negative pregnancy test at the screening visit and use effective contraception as determined by the physician of the patient throughout the study.
Exclusion Criteria
* Patients whose tumor resection is incomplete
* Patients with an indication of mastectomy
* Patients with a history of radiation therapy of the chest
* Pregnant women, lactating, or of childbearing age without effective contraception.
* Patients who had more than 4 scanners in one year. ( Scanner cervical , thoracic, or abdominal
* Patients with an incompatible condition with monitoring protocol (psychiatric disorder, uncontrolled disease).
* Patient unable to respond to a questionnaire
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Center of Martinique
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincent VINH HUNG, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Martinique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Martinique
Fort-de-France, , Martinique
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15/ B/ 25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.